156 related articles for article (PubMed ID: 32108038)
1.
Panagopoulos I; Gorunova L; Lobmaier I; Andersen K; Kostolomov I; Lund-Iversen M; Bjerkehagen B; Heim S
Cancer Genomics Proteomics; 2020; 17(2):161-168. PubMed ID: 32108038
[TBL] [Abstract][Full Text] [Related]
2. Fusion of the
Panagopoulos I; Gorunova L; Lobmaier I; Lund-Iversen M; Andersen K; Holth A; Bjerkehagen B; Heim S
Cancer Genomics Proteomics; 2019; 16(5):361-368. PubMed ID: 31467230
[TBL] [Abstract][Full Text] [Related]
3. Recurrent rearrangements of FOS and FOSB define osteoblastoma.
Fittall MW; Mifsud W; Pillay N; Ye H; Strobl AC; Verfaillie A; Demeulemeester J; Zhang L; Berisha F; Tarabichi M; Young MD; Miranda E; Tarpey PS; Tirabosco R; Amary F; Grigoriadis AE; Stratton MR; Van Loo P; Antonescu CR; Campbell PJ; Flanagan AM; Behjati S
Nat Commun; 2018 Jun; 9(1):2150. PubMed ID: 29858576
[TBL] [Abstract][Full Text] [Related]
4. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.
Saba KH; Cornmark L; Hofvander J; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Foijer F; Staaf J; Brosjö O; Sumathi VP; Lam SW; Szuhai K; Bovée JV; Kovac M; Baumhoer D; Styring E; Nord KH
J Pathol Clin Res; 2020 Oct; 6(4):231-237. PubMed ID: 32542935
[TBL] [Abstract][Full Text] [Related]
5. Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors.
Panagopoulos I; Brandal P; Gorunova L; Bjerkehagen B; Heim S
Int J Oncol; 2014 May; 44(5):1425-32. PubMed ID: 24604026
[TBL] [Abstract][Full Text] [Related]
6. Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.
Nord KH; Nilsson J; Arbajian E; Vult von Steyern F; Brosjö O; Cleton-Jansen AM; Szuhai K; Hogendoorn PC
PLoS One; 2013; 8(11):e80725. PubMed ID: 24236197
[TBL] [Abstract][Full Text] [Related]
7. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.
Dancer JY; Henry SP; Bondaruk J; Lee S; Ayala AG; de Crombrugghe B; Czerniak B
Hum Pathol; 2010 Dec; 41(12):1788-93. PubMed ID: 21078438
[TBL] [Abstract][Full Text] [Related]
8. Osteoblastoma of the thumb with a novel PRSS44::ALK fusion and literature review of osteoblastoma of hands and feet bones.
Brandea AI; Afkhami M; Klein MJ; Bell D
Genes Chromosomes Cancer; 2024 May; 63(5):e23241. PubMed ID: 38738966
[TBL] [Abstract][Full Text] [Related]
9. Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?
Ameline B; Nathrath M; Nord KH; de Flon FH; Bovée JVMG; Krieg AH; Höller S; Hench J; Baumhoer D
Mod Pathol; 2022 Sep; 35(9):1204-1211. PubMed ID: 35347251
[TBL] [Abstract][Full Text] [Related]
10. Osteoblastoma characterized by a three-way translocation: report of a case and review of the literature.
Giannico G; Holt GE; Homlar KC; Johnson J; Pinnt J; Bridge JA
Cancer Genet Cytogenet; 2009 Dec; 195(2):168-71. PubMed ID: 19963118
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors.
Möller E; Mandahl N; Mertens F; Panagopoulos I
Genes Chromosomes Cancer; 2008 Jan; 47(1):21-5. PubMed ID: 17918257
[TBL] [Abstract][Full Text] [Related]
12. FOS Rearrangement and Expression in Cementoblastoma.
Lam SW; Cleven AHG; Briaire-de Bruijn IH; Schreuder WH; Kroon HM; Savci-Heijink DC; Suurmeijer AJH; Szuhai K; Bovée JVMG; Baumhoer D
Am J Surg Pathol; 2021 May; 45(5):690-693. PubMed ID: 33653978
[TBL] [Abstract][Full Text] [Related]
13. Nuclear p63 expression in osteoblastic tumors.
Kallen ME; Sanders ME; Gonzalez AL; Black JO; Keedy VL; Hande KR; Homlar KC; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Cates JM
Tumour Biol; 2012 Oct; 33(5):1639-44. PubMed ID: 22623071
[TBL] [Abstract][Full Text] [Related]
14. New kids on the block:
Cordier F; Creytens D
J Clin Pathol; 2023 Nov; 76(11):721-726. PubMed ID: 37553246
[No Abstract] [Full Text] [Related]
15. Clinicopathologic study of 6 cases of epithelioid osteoblastoma of the jaws with immunoexpression analysis of FOS and FOSB.
Pereira TDSF; Andrade BAB; Romañach MJ; Pereira NB; Gomes CC; Mariz BALA; Almeida OP; Agostini M; van Heerden WFP; Carlos R; Gomez RS; Fonseca FP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):191-199. PubMed ID: 32482537
[TBL] [Abstract][Full Text] [Related]
16. Aggressive osteoblastoma: a case report involving a unique chromosomal aberration.
Baker AC; Rezeanu L; Klein MJ; Pitt MJ; Buecker P; Hersh JH; Buchino JJ; Siegal GP
Int J Surg Pathol; 2010 Jun; 18(3):219-24. PubMed ID: 18611933
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (
Panagopoulos I; Andersen K; Gorunova L; Lund-Iversen M; Lobmaier I; Heim S
Cancer Genomics Proteomics; 2022; 19(2):163-177. PubMed ID: 35181586
[TBL] [Abstract][Full Text] [Related]
18. RUNX2 expression in developing human bones and various bone tumors.
Sugawara M; Kato N; Tsuchiya T; Motoyama T
Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
[TBL] [Abstract][Full Text] [Related]
19. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.
Tsuda Y; Hirata M; Katayama K; Motoi T; Matsubara D; Oda Y; Fujita M; Kobayashi H; Kawano H; Nishida Y; Sakai T; Okuma T; Goto T; Ogura K; Kawai A; Ae K; Anazawa U; Suehara Y; Iwata S; Miyano S; Imoto S; Shibata T; Nakagawa H; Yamaguchi R; Tanaka S; Matsuda K
Int J Cancer; 2019 Dec; 145(12):3276-3284. PubMed ID: 31107544
[TBL] [Abstract][Full Text] [Related]
20. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]